Part D/Prescription Drugs – Page 32 – medicarereport.org

Friday, September 11, 2026

Latest:

Aging Alzheimer’s/Dementia FDA Part D/Prescription Drugs Women’s Health

Eileen Cook June 18, 2024June 18, 2024 FDA, Older Adults, Older Women, Prescription Drugs, Women’s Health, Women’s Health Research

Older Women Are Different Than Older Men. Their Health Is Woefully Understudied.

(By Judith Graham for KFF Health News) Medical research has shortchanged women for decades. This is particularly true of older

Affordable Care Act (ACA)Emerging Health Issues Health Care Finance Health Insurance Part D/Prescription Drugs

Eileen Cook June 14, 2024June 14, 2024 ACA, Drugs for Weight Loss, GLP-1s drugs, Healthcare Costs, Healthcare Finance, Ozempic, Wegovy

Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans

(By Tammie Smith for The Kaiser Family Foundation published June 12, 2024) Affordable Care Act (ACA) Marketplace plans rarely cover

Elections - Healthcare issues Health Care Finance Health Care Redesign Medicare - General Part D/Prescription Drugs

Eileen Cook June 13, 2024June 13, 2024 CMS, Copay Cap, Elections, Healthcare Costs, Healthcare Finance, medicare, Medicare Insulin Cost-sharing, Medicare Part D

The Facts About the $35 Insulin Copay Cap in Medicare

(By Juliette Cubanski and Tricia Neuman for The Kaiser Family Foundation Published: Jun 12, 2024) In a recent post on

CMS Health Care Finance Health Insurance Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook June 13, 2024June 13, 2024 CMS, Healthcare Costs, Healthcare Finance, Medicaid, medicare, Medicare Part D

US health spending to top $7.7 trillion by 2032: CMS

(By Naomi Diaz for Becker’s Hospital Review ) CMS expects national health spending to reach $7.7 trillion by 2032, with

Alzheimer’s/Dementia FDA Part D/Prescription Drugs

Eileen Cook June 11, 2024June 11, 2024 Alzheimer’s Treatment, Donanemab, FDA, Healthcare Costs, Medicare Part D, Older Adults

FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations

(By Jon Hamilton for NPR) Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the

CMS Health Care Finance Health Insurance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook June 11, 2024June 11, 2024 CMS, Healthcare Costs, Healthcare Finance, independent pharmacies, medicare, Medicare Advantage, Medicare Part D, Older Adults, PBM, The Inflation Reduction Act

Biden Plan to Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say

(By Susan Jaffe for KFF Health News) Months into a new Biden administration policy intended to lower drug costs for

Health Care Finance Medicaid Medicare Advantage Part D/Prescription Drugs

Eileen Cook June 7, 2024June 7, 2024 CMS, D-SNP Prior Authorization Denial, Dual Eligible, Medicaid, Medicare Advantage, Medicare Part D, Older Adults

D-SNP prior auth denial rates twice as high as all Medicare Advantage

(By Jakob Emerson for Becker’s Hospital Review ) Dual-eligible special needs plan enrollees are twice as likely to have prior

CMS Emerging Health Issues Health Care Finance Health Insurance Medicare - General Part D/Prescription Drugs

Eileen Cook June 4, 2024June 4, 2024 CMS, GLP-1s drugs, Health Insurance companies, Healthcare Costs, Healthcare Finance, medicare, Medicare Part D, Older Adults

Weight loss drug coverage gets more complicated

(By Jakob Emerson for Becker’s Hospital Review ) In less than a month’s time, a federal lawmaker warned weight loss

Alzheimer’s/Dementia CMS Medicare - General Part D/Prescription Drugs

Eileen Cook June 4, 2024June 4, 2024 Alzheimer’s Disease, CMS, Dementia, medicare, Medication, Older Adults

Outdated Medicare rules prevent some dementia patients from getting the medications they need

(By Carolyn Clevenger for ST A T) Memory loss is the most obvious symptom of Alzheimer’s disease. But for the